Sotrovimab for Treatment of COVID-19 in Solid Organ Transplant Recipients

Transplantation. 2022 Jul 1;106(7):e336-e337. doi: 10.1097/TP.0000000000004136. Epub 2022 Apr 15.

Authors

Abhay Dhand^{1

2}, Kenji Okumura², Kevin Wolfe², Stephen A Lobo¹, Rajat Nog^{1

2}, Marina Keller¹, Roxana Bodin^{1

2}, Nandita Singh^{1

2}, Avi Levine³, Christopher Nabors¹

Affiliations

¹ Department of Medicine, Westchester Medical Center, Valhalla, NY.
² Department of Surgery, Westchester Medical Center, Valhalla, NY.
³ Department of Cardiology, Westchester Medical Center, Valhalla, NY.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Antibodies, Neutralizing
COVID-19*
Humans
Organ Transplantation* / adverse effects
Transplant Recipients

Substances

Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
sotrovimab